Cargando…
The Future of Sleeve Gastrectomy
The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Touch Medical Media
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813458/ https://www.ncbi.nlm.nih.gov/pubmed/29632587 http://dx.doi.org/10.17925/EE.2016.12.01.37 |
_version_ | 1783300201051586560 |
---|---|
author | Gagner, Michel |
author_facet | Gagner, Michel |
author_sort | Gagner, Michel |
collection | PubMed |
description | The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications and decrease costs in severely obese patients. Laparoscopic sleeve gastrectomy has been shown to be effective for the treatment of type 2 diabetes, with extremely low mortality and acceptable morbidity. It decreases caloric consumption, modifies gut hormones, changes gastric emptying, and lowers glycaemia. In the long term, if recurrences in weight or diabetes occur, it can be converted to a duodenal switch, potentially reaching 90% of patients with partial or complete remission. |
format | Online Article Text |
id | pubmed-5813458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Touch Medical Media |
record_format | MEDLINE/PubMed |
spelling | pubmed-58134582018-04-09 The Future of Sleeve Gastrectomy Gagner, Michel Eur Endocrinol Obesity and Weight Management Editorial The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications and decrease costs in severely obese patients. Laparoscopic sleeve gastrectomy has been shown to be effective for the treatment of type 2 diabetes, with extremely low mortality and acceptable morbidity. It decreases caloric consumption, modifies gut hormones, changes gastric emptying, and lowers glycaemia. In the long term, if recurrences in weight or diabetes occur, it can be converted to a duodenal switch, potentially reaching 90% of patients with partial or complete remission. Touch Medical Media 2016-03 2016-03-15 /pmc/articles/PMC5813458/ /pubmed/29632587 http://dx.doi.org/10.17925/EE.2016.12.01.37 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by/2.5/ This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit. |
spellingShingle | Obesity and Weight Management Editorial Gagner, Michel The Future of Sleeve Gastrectomy |
title | The Future of Sleeve Gastrectomy |
title_full | The Future of Sleeve Gastrectomy |
title_fullStr | The Future of Sleeve Gastrectomy |
title_full_unstemmed | The Future of Sleeve Gastrectomy |
title_short | The Future of Sleeve Gastrectomy |
title_sort | future of sleeve gastrectomy |
topic | Obesity and Weight Management Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813458/ https://www.ncbi.nlm.nih.gov/pubmed/29632587 http://dx.doi.org/10.17925/EE.2016.12.01.37 |
work_keys_str_mv | AT gagnermichel thefutureofsleevegastrectomy AT gagnermichel futureofsleevegastrectomy |